David H O'Connor Selected Research

David H O'Connor Research Topics

Disease

41	Infections 02/2024 - 05/2002
12	COVID-19 12/2023 - 01/2020
9	Zika Virus Infection 02/2024 - 11/2016
9	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 11/2002
8	Communicable Diseases (Infectious Diseases) 01/2023 - 07/2008
6	Viremia 01/2022 - 12/2005
6	HIV Infections (HIV Infection) 12/2014 - 08/2003
5	Persistent Infection 11/2022 - 08/2003
5	Disease Progression 01/2019 - 09/2002
4	Neoplasms (Cancer) 11/2022 - 01/2011
4	Virus Diseases (Viral Diseases) 02/2014 - 05/2002
2	Congenital Abnormalities (Deformity) 01/2019 - 01/2017
2	Coinfection 01/2019 - 07/2013
1	Dengue (Dengue Fever) 02/2024
1	Varicella Zoster Virus Infection 01/2022
1	T-Cell Leukemia (Leukemia, T Cell) 10/2021
1	Autistic Disorder (Autism) 12/2020
1	Microcephaly 10/2019
1	Guillain-Barre Syndrome 01/2019
1	Neglected Diseases 11/2018
1	Disease Susceptibility (Diathesis) 04/2017
1	Malaria 01/2017
1	Hepatitis C 01/2017
1	Fever (Fevers) 02/2016
1	Necrosis 02/2016
1	Lethargy 02/2016
1	Epstein-Barr Virus Infections 12/2013
1	Adenocarcinoma 01/2011
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2011
1	Papillomavirus Infections 01/2011
1	Influenza in Birds (Avian Flu) 08/2010
1	Superinfection 07/2010
1	Chronic Disease (Chronic Diseases) 06/2004
1	Vaccinia 10/2002

Drug/Important Bio-Agent (IBA)

21	VaccinesIBA 11/2021 - 09/2002
14	EpitopesIBA 01/2023 - 10/2002
11	Peptides (Polypeptides)IBA 01/2021 - 05/2002
10	AntibodiesIBA 02/2024 - 04/2017
10	Proteins (Proteins, Gene)FDA Link 01/2023 - 10/2002
6	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 10/2002
5	Immunoglobulin G (IgG)IBA 02/2024 - 11/2018
4	Antiviral Agents (Antivirals)IBA 01/2023 - 10/2015
4	Amino Acids FDA Link 01/2022 - 10/2004
4	ProteomeIBA 01/2021 - 10/2013
4	CytokinesIBA 01/2019 - 10/2002
3	Neutralizing AntibodiesIBA 02/2024 - 06/2006
3	WastewaterIBA 12/2023 - 06/2022
3	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 03/2011
3	LigandsIBA 11/2018 - 03/2011
2	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 01/2021 - 01/2021
2	Angiotensin-Converting Enzyme 2IBA 01/2021 - 01/2021
2	Complementary DNA (cDNA)IBA 01/2021 - 07/2008
2	RNA (Ribonucleic Acid)IBA 01/2016 - 10/2015
2	AIDS VaccinesIBA 08/2014 - 10/2002
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 12/2013 - 10/2002
2	antineoplaston A10 (A 10)IBA 08/2011 - 10/2005
2	Histocompatibility Antigens Class IIBA 11/2005 - 11/2002
1	Monoclonal AntibodiesIBA 02/2024
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	COVID-19 VaccinesIBA 01/2022
1	varicella-zoster immune globulin (VZIG)IBA 01/2022
1	GlobulinsIBA 01/2022
1	Enzyme Precursors (Zymogens)IBA 10/2021
1	Ribonucleases (Ribonuclease)IBA 10/2021
1	AntigensIBA 01/2021
1	enhanced green fluorescent proteinIBA 01/2021
1	NucleotidesIBA 12/2020
1	Nucleic AcidsIBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Monocyte Chemoattractant ProteinsIBA 01/2019
1	InterleukinsIBA 01/2019
1	Broadly Neutralizing AntibodiesIBA 01/2019
1	InterferonsIBA 01/2019
1	HLA-DR Antigens (HLA-DR)IBA 07/2017
1	KIR ReceptorsIBA 01/2017
1	Bone Marrow Stromal Antigen 2IBA 12/2016
1	Dextran SulfateIBA 12/2016
1	Chloroquine (Aralen)FDA LinkGeneric 11/2016
1	EnzymesIBA 02/2016
1	EBV-encoded nuclear antigen 1IBA 12/2013
1	Cytochromes b (Cytochrome b)IBA 07/2013
1	ChemokinesIBA 04/2013
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 04/2011
1	HLA-A Antigens (HLA-A)IBA 01/2011
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2011
1	Chemokine CCL5IBA 01/2011
1	Cancer VaccinesIBA 01/2011
1	Cysteine (L-Cysteine)FDA Link 01/2011
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2010
1	Lysine (L-Lysine)FDA Link 08/2010
1	AsparagineIBA 08/2010
1	integrin alpha4beta7IBA 07/2010
1	Mamu-A 02 antigenIBA 10/2004

Therapy/Procedure

6	Transplantation 01/2023 - 07/2008
6	Therapeutics 01/2023 - 12/2014
2	Immunotherapy 12/2020 - 12/2013
1	Personal Protective Equipment 10/2020
1	Euthanasia (Mercy Killing) 12/2004